North China Pharmaceutical Company Ltd. Class ASSE: 600812

Announcement on Cashing Completion of Phase I Short-term Financing Bonds of 2025

· Issued by North China Pharmaceutical Company Ltd. Class A via Shanghai Stock Exchange
Announcement on Cashing Completion of Phase I Short-term Financing Bonds of 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment